Received Jul 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | X023975 | — |
No adverse effects; patient inadvertently received expired dose of VAQTA; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 01-Jul-2025, the patient was inadvertently vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) (lot #X023975, expiration date: 18-Apr-2025), administered for prophylaxis (strength, dose, and route were not reported) (Expired product administered). There was no temperature excursion. Dose was supported per post expiry memo. No adverse effects reported.